Photodynamic Therapy with Targeted Release of Boron-Dipyrromethene Dye from Cobalt(III) Prodrugs in Red Light
Inorganic Chemistry · 2024
DOI: 10.1021/acs.inorgchem.4c00244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2024. Verfasst von Avishek Jana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inorganic and Physical Chemistry, Indian Institute of Science, Sir C.V. Raman Avenue, Bangalore 560012, India. Hauptthemen laut MEDLINE: Photochemotherapy, Prodrugs, Antineoplastic Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Indian National Science Academy, Science and Engineering Research Board, Indian Institute of Science.
Abstract (Originalsprache)
Boron-dipyrromethene (BODIPY) dyes are promising photosensitizers for cellular imaging and photodynamic therapy (PDT) owing to their excellent photophysical properties and the synthetically tunable core. Metalation provides a convenient way to overcome the drawbacks arising from their low aqueous solubility. New photo-/redox-responsive Co(III) prodrug chaperones are developed as anticancer PDT agents for efficient cellular delivery of red-light-active BODIPY dyes. The photobiological activity of heteroleptic Co(III) complexes derived from tris(2-pyridylmethyl)amine (TPA) and acetylacetone-conjugated PEGylated distyryl BODIPY (HL1) or its dibromo analogue (HL2), [CoIII(TPA)(L1/L2)](ClO4)2 (1 and 2), are investigated. The Co(III)/Co(II) redox potential is tuned using the Co(III)-TPA scaffold. Complex 1 displays the in vitro release of BODIPY on red light irradiation. Complex 2, having good singlet oxygen quantum yield (ΦΔ ∼ 0.28 in DMSO), demonstrates submicromolar photocytotoxicity to HeLa cancer cells (IC50 ≈ 0.23 μM) while being less toxic to HPL1D normal cells in red light. Cellular imaging using the emissive complex 1 shows mitochondrial localization and significant penetration into the HeLa tumor spheroids. Complex 2 shows supercoiled DNA photocleavage activity and apoptotic cell death through phototriggered generation of reactive oxygen species. The Co(III)-BODIPY prodrug conjugates exemplify new type of phototherapeutic agents with better efficacy than the organic dyes alone in the phototherapeutic window.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Inorganic and Physical Chemistry, Indian Institute of Science, Sir C.V. Raman Avenue, Bangalore 560012, India.
- Department of Biochemistry, Indian Institute of Science, Sir C.V. Raman Avenue, Bangalore 560012, India.
ORCID-Profile: Akhil R Chakravarty
Förderung
- Indian National Science Academy
- Science and Engineering Research Board
- Indian Institute of Science
Zitieren
APA
Jana, A., Sahoo, S., Paul, S., Sahoo, S., Jayabaskaran, C., & Chakravarty, A. R. (2024). Photodynamic Therapy with Targeted Release of Boron-Dipyrromethene Dye from Cobalt(III) Prodrugs in Red Light. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.4c00244
Vancouver
Jana A, Sahoo S, Paul S, Sahoo S, Jayabaskaran C, Chakravarty AR. Photodynamic Therapy with Targeted Release of Boron-Dipyrromethene Dye from Cobalt(III) Prodrugs in Red Light. Inorganic Chemistry. 2024. doi:10.1021/acs.inorgchem.4c00244
BibTeX
@article{Jana2024,
author = {Jana, Avishek and Sahoo, Subhadarsini and Paul, Subhadeep and Sahoo, Somarupa and Jayabaskaran, Chelliah and Chakravarty, Akhil R},
title = {Photodynamic Therapy with Targeted Release of Boron-Dipyrromethene Dye from Cobalt(III) Prodrugs in Red Light},
journal = {Inorganic Chemistry},
year = {2024},
doi = {10.1021/acs.inorgchem.4c00244}
}
EUVIMED